Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial
Publication year
2021Source
Lancet Neurology, 20, 11, (2021), pp. 907-916ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Neurology
Internal Medicine
Radboudumc Extern
Journal title
Lancet Neurology
Volume
vol. 20
Issue
iss. 11
Page start
p. 907
Page end
p. 916
Subject
All institutes and research themes of the Radboud University Medical Center; Radboudumc 16: Vascular damage RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 3: Disorders of movement DCMN: Donders Center for Medical NeuroscienceThis item appears in the following Collection(s)
- Academic publications [227425]
- Faculty of Medical Sciences [86157]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.